Aurobindo Pharma – Recall of valsartan-containing products
February 25, 2019 - Aurobindo Pharma announced a voluntary, consumer-level recall of several lots of valsartan and amlodipine/valsartan tablets due to the detection of trace amounts of an unexpected impurity, identified as N-nitrosodiethylamine (NDEA).
Top